HI
TTPH

HBK Investments’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

HBK Investments’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,510
Closed -$3.33M – 1178
2015
Q2 		$3.33M Buy
3,510
+150
+4% +$123K 0.03% 288
2015
Q1 		$2.46M Buy
+3,360
New +$2.52M 0.02% 359

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

HBK Investments's TTPH Position: Q3 2015 in Review

HBK Investments sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2015, closing a stake of 3,510 shares — an estimated $3.33M sold.

HBK Investments first reported a position in TTPH in Q1 2015 and held it in 2 quarters. The position peaked at $3.33M in Q2 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q3 2015.

  • HBK Investments reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • HBK Investments sold 3,510 Tetraphase Pharmaceuticals, Inc. shares in Q3 2015, an estimated $3.33M.
  • HBK Investments first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 2 quarters.
  • HBK Investments's Tetraphase Pharmaceuticals, Inc. position peaked at $3.33M in Q2 2015.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2015.

Based on HBK Investments's 13F filing for Q3 2015, filed 16 Nov 2015.